Growth hormone production and action in N1E-115 neuroblastoma cells

Journal of Molecular Neuroscience

Volumn 39, Issue 1-2, 2009, Pages 117-124

  Grimbly, Chelsey ^a   Martin, Brent ^a   Karpinski, Edward ^a   Harvey, Steve ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

GH receptor (GHR); Growth hormone (GH); Neural cancer; Neurites; Neuroblastoma cells

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; HORMONE SYNTHESIS; MOUSE; NERVE FIBER GROWTH; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE, TUMOR; GROWTH HORMONE; MICE; NEUROBLASTOMA; RECEPTORS, SOMATOTROPIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 74149085730     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9194-7     Document Type: Article

References (53)

1. Åberg, N. D., Brywe, K. G., & Isgaard, J. (2006). Aspects of growth hormone and insulin-like growth factor-1 related to neuroprotection, regeneration, and functional plasticity in the adult brain. Science World Journal, 6, 53-80.
2. Amano, T., Richelson, E., & Niremberg, M. (1972). Neurotransmitter synthesis by neuroblastoma clones. Proceedings of the National Academy of Sciences of the United States of America, 69, 258-263. doi:10.1073/pnas.69. 1.258.
3. Barann, M., Göthert, M., Brüss, M., & Bönisch, H. (1999). Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology, 360, 234-241. doi:10.1007/s002109900089.
4. Baudet, M.-L., Sanders, E. J., & Harvey, S. (2003). Retinal growth hormone in the chick embryo. Endocrinology, 144, 5459-5468. doi:10.1210/en. 2003-0651.
5. Byts, N., Samoylenko, A., Fasshauer, T., Ivanisevic, M., Henninghausen, L., Ehrenreigh, H., et al. (2008). Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death and Differentiation, 15, 783-792. doi:10.1038/cdd.2008.1.
6. Donahue, C. P., Kosik, K., & Shors, T. J. (2006). Growth hormone is produced within the hippocampus where it responds to age, sex and stress. Proceedings of the National Academy of Sciences of the United States of America, 103, 6031-6036. doi:10.1073/pnas.0507776103.
7. Dunlop, M. E., Hill, M. A., & Larkins, R. G. (1988). The influence of insulin and sorbinil on myoinositol uptake in peripheral nerve from normal and diabetic rats and a neuroblastoma cell line (N1E-115). Diabetes Research (Edinburgh, Lothian), 8, 51-57.
8. Favier, J., Lapointe, S., Maliba, R., & Sirois, M. G. (2007). HIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma. BMC Cancer, 7, 139-148. doi:10.1186/1471-2407-7-139.
9. Friend, K. E., Khandwala, H. M., Flyvbjerg, A., Hill, H., Li, J., & McCutcheon, I. E. (2001). Growth hormone and insulin-like growth factor-1: effects on the growth of glioma cell lines. Growth Hormone & IGF Research, 11, 84-91. doi:10.1054/ghir.2000.0183.
10. Gossard, F., Kihi, F., Pelletier, G., Dubois, P. M., & Morel, G. (1987). In situ hybridization to rat brain and pituitary gland of growth hormone cDNA. Neuroscience Letters, 79, 251-256. doi:10.1016/0304-3940 (87) 90438-1.
11. Harvey, S., & Hull, K. (2003). Neural growth hormone: an update. Journal of Molecular Neuroscience, 20, 1-14. doi:10.1385/JMN:20:1:1.
12. Harvey, S., Hull, K. L., & Fraser, R. A. (1993). Growth hormone: neurocrine and neuroendocrine perspectives. Growth Regulation, 3, 161-171.
13. Hull, K. L., & Harvey, S. (2006). Growth hormone and cancer. In G. V. Sherbet (Ed.), The molecular and cellular pathology of cancer progression and prognosis (pp. 97-138). Trivandrum, India: Research Signpost.
14. Hull, K. L., Sanders, E. J., & Harvey, S. (1995). Synthesis and release of growth hormone binding proteins in tumorous somatolactotrophs. Endocrine, 3, 461-467.
15. Kaulsay, K. K., Mertani, H. C., Tornell, J., Morel, G., Lee, K. O., & Lobie, P. E. (1999). Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Experimental Cell Research, 250, 35-50. doi:10.1006/excr. 1999.4492.
16. Kisaalita, W. S., & Bowen, J. M. (1996). Effect of culture age on the susceptibility of differing neuroblastoma cells to retinoid cytotoxicity. Biotechnology and Bioengineering, 50, 580-586. doi:10.1002/(SICI) 1097-0290 (19960605) 50:5<580::AID-BIT13>3.0.CO;2-N.
17. Kisaalita, W. S., & Bowen, J. M. (1997). Effect of medium serum concentration on N1E-115 neuroblastoma membrane potential development. In Vitro Cellular & Developmental Biology Animal, 33, 152-155. doi:10.1007/s11626-997-0133-z.
18. Kwon, M., Godinho, S. A., Chan d hok, N. S., Ganem, N. J., Azioune, A., Thery, M., et al. (2008). Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes & Development, 22, 2189-2203. doi:10.1101/gad.1700908.
19. Lyuh, E., Kim, H. J., Kim, M., Lee, J. K., Park, K. S., Yoo, K. Y., et al. (2007). Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of culture neuronal cells. Growth Hormone & IGF Research, 17, 315-322. doi:10.1016/j.ghir.2007.03.002.
20. Marler, K. J., Kozma, R., Ahmed, S., Dong, J. M., Hall, C., & Lim, L. (2005). Outgrowth of neurites from N1E-115 neuroblastoma cells is prevented on repulsive substrates through the action of PAK. Molecular and Cellular Biology, 12, 5226-5241. doi:10.1128/MCB.25.12.5226-5241.2005.
21. Martinoli, M. G., Oullet, J., Rhlaume, E., & Pelletier, G. (1991). Growth hormone and somatostatin gene expression in adult and aging rats as measured by quantitative in situ hybridization. Neuroendocrinology, 54, 607-615. doi:10.1159/000125967.
22. McKinney, M., & Barrett, R. W. (1989). Biochemical evidence for somatostatin receptors in murine neuroblastoma clone N1E-115. European Journal of Pharmacology, 162, 397-405. doi:10.1016/0014-2999 (89) 90330-0.
23. Möderscheim, T. A. E., Christophidis, L. J., Williams, C. E., & Scheepens, A. (2007). Distinct neuronal growth hormone receptor ligand specificity in the rat brain. Brain Research, 1137, 29-34. doi:10.1016/j.brainres.2006.12.040.
24. Mukhina, S., Mertaini, H. C., Guo, K., Lee, K. O., Gluckman, P. D., & Lobie, P. E. (2004). Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proceedings of the National Academy of Sciences of the United States of America, 101, 15166-15171. doi:10.1073/pnas.0405881101.
25. Mummery, C. L., van den Brink, C. E., van der Saag, P. T., & de Laat, S. W. (2005). A short-term screening test for teratogens using differentiating neuroblastoma cells in vitro. Experimental Teratology, 29, 271-279. doi:10.1002/tera.1420290213.
26. Nyberg, F. (2000). Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Frontiers in Neuroendocrinology, 21, 330-348. doi:10.1006/frne.2000.0200.
27. Nyberg, F., & Burman, P. (1996). Growth hormone and its receptors in the central nervous system-location and functional significance. Hormone Research, 45, 18-22. doi:10.1159/000184753.
28. Ostlund, P., Lindegren, H., Pettersson, C., & Bedecs, K. (2001). Altered insulin receptor processing and function in scrapie-infected neuroblastoma cell lines. Brain Research Molecular Brain Research, 97, 161-170. doi:10.1016/S0169-328X (01) 00316-3.
29. Pandey, V., Perry, J. K., Mohankumar, K. M., Kong, X. J., Liu, S. M., Wu, Z. S., et al. (2008). Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. Endocrinology, 149, 3909-3919. doi:10.1210/en. 2008-0286.
30. Pang, P. K., Wang, R., Shan, J., Karpinski, E., & Benishin, C. G. (1990). Specific inhibition of long-lasting, L-type calcium channels by synthetic parathyroid hormone. Proceedings of the National Academy of Sciences of the United States of America, 87, 623-627. doi:10.1073/pnas.87. 2.623.
31. Parsons, S. A., Banks, G. B., Rowland, J. A., Coschigano, K. T., Kopchick, J. J., Waters, M. J., et al. (2003). Genetic disruption of the growth hormone receptor does not influence motoneuron survival in the developing mouse. The International Journal of Developmental Biology, 47, 41-49.
32. Perry, J. K., Emerald, B. S., Mertani, H. C., & Lobie, P. E. (2006). The oncogenic potential of growth hormone. Growth Hormone & IGF Research, 16, 277-289. doi:10.1016/j.ghir.2006.09.006.
33. Prasad, K. N. (1991). Differentiation of neuroblastoma cells: a useful model for neurobiology and cancer. Biological Reviews of the Cambridge Philosophical Society, 66, 431-451. doi:10.1111/j.1469-185X.1991.tb01148.x.
34. Render, C. L., Hull, K. L., & Harvey, S. (1995). Neural expression of the pituitary GH gene. The Journal of Endocrinology, 147, 413-422. doi:10.1677/joe.0.1470413.
35. Rodrigues, J. M., Luis, A. L., Lobato, J. V., Pinto, M. V., Lopes, M. A., Freitas, M., et al. (2005). Determination of the intracellular Ca2+ concentration in the N1E-115 neuronal cell gene in perspective of its use for peripheric nerve regeneration. Bio-Medical Materials and Engineering, 6, 455-465.
36. Russell, J. W., Windebank, A. J., McNive, M. A., Brat, D. J., & Brimijoin, W. S. (1995). Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Research, 676, 258-267. doi:10.1016/0006-8993 (95) 00100-5.
37. Sanders, E. J., Parker, E., Arámburo, C., & Harvey, S. (2005). Retinal growth hormone is an anti-apoptotic factor in embryonic retinal ganglion cell differentiation. Experimental Eye Research, 81, 551-560. doi:10.1016/j.exer.2005.03.013.
38. Sanders, E. J., Parker, E., & Harvey, S. (2008). Growth hormonemediated survival of embryonic retinal ganglion cells: signaling mechanisms. General and Comparative Endocrinology, 156, 613-621. doi:10.1016/j.ygcen. 2008.02.005.
39. Scheepens, A., Möderscheim, T. A., & Gluckman, P. D. (2005). The role of growth hormone in neural development. Hormone Research, 64, 66-72. doi:10.1159/000089320.
40. Schelman, W. R., Andreas, R., Feguson, P., Orr, B., Kang, E., & Weyhenmeyer, J. A. (2004). Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in bcl-2 expression. Brain Research. Molecular Brain Research, 128, 20-29. doi:10.1016/j.molbrainres. 2004.06.001.
41. Schwarz, P. M., Gierten, B., Biossel, J. P., & Förstermann, U. (1998). Expressional down-regulation of neuronal-type nitric oxide synthase I by glucocorticoids in N1E-115 neuroblastoma cells. Molecular Pharmacology, 54, 258-263.
42. Scott, H. J., Stebbing, M. J., Walters, C. E., McLenachan, S., Ransome, M. I., Nichols, N. R., et al. (2006). Differential effects of SOGS2 on neuronal differentiation and morphology. Brain Research, 1067, 138-145. doi:10.1016/j.brainres.2005.10.032.
43. Shastry, P., Basu, A., & Rajadhyaksha, M. S. (2001). Neuroblastoma cell lines-a versatile in vitro model in neurobiology. The International Journal of Neuroscience, 108, 109-126. doi:10.3109/00207450108986509.
44. Sun, L. Y., Evans, M. S., Hsieh, J., Panici, J., & Bathe, A. (2005a). Increased neurogenesis in the dentate gyrus of long-lived Ames dwarf mice. Endocrinology, 146, 1138-1144. doi:10.1210/en. 2004-1115.
45. Sun, L. Y., Al-Regaiey, K., Maternak, M. M., Wang, J., & Bartke, A. (2005b). Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiology of Aging, 26, 929-937. doi:10.1016/j. neurobiolaging.2004.07.010.
46. Thiele, C. J. (1999). Neuroblastoma cell lines. In J. Masters (Ed.), Human cell culture (pp. 21-53). Lancaster, UK: Kluwer Academic Publishers.
47. Turnley, A. M. (2005). Growth hormone and SOCS2 regulation of neuronal differentiation: possible role in mental function. Pediatric Endocrinology Reviews, 2, 366-371.
48. Turnley, A. M., Faux, C. H., Rietze, R. L., Coonan, J. R., & Bartlett, P. F. (2002). Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nature Neuroscience, 5, 1155-1162. doi:10.1038/nn954.
49. Waters, M. J., & Barclay, J. L. (2007). Does growth hormone drive breast and other cancers. Endocrinology, 148, 4533-4535. doi:10.1210/en. 2007-0855.
50. Xu, X. Q., Emerald, B. S., Goh, E. L., Kannan, N., Miller, L. D., Gluckman, P. D., et al. (2005). Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma. The Journal of Biological Chemistry, 280, 23987-24003. doi:10.1074/jbc. M503869200.
51. Yoshizato, H., Fujikawa, T., Soya, H., Tanada, M., & Nakashima, K. (1998). The growth hormone (GH) gene is expressed in the lateral hypothalamus: enhancement by GH releasing hormone and repression by rest and stress. Endocrinology, 39+, 2545-2551.
52. Yoshizato, H., Fujikawa, T., Shibata, M., Tanada, M., & Nakashima, K. (1999). Stimulation of growth hormone gene expression in the pituitary and brain by panaxginseng CA Meyer. Endocrine Journal, 4 (suppl), 858-588.
53. Zhu, T., Starling-Emerald, B., Zhang, X., Lee, K. O., Gluckman, P. D., Mertani, H. C., et al. (2005). Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Research, 65, 317-324.